DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Kilitch Drugs Publishes Quarterly Results in Marathi and English Dailies

TipRanks 14 hrs ago·18 Aug 2026, 5:56 pm

Kilitch Drugs India

Kilitch Drugs India has published its quarterly results in both Marathi and English newspapers, a move that highlights the company's strong focus on its domestic consumer base in Maharashtra. This dual-language disclosure is a standard corporate practice in India, aimed at ensuring that the company's financial updates are accessible to a wider demographic of shareholders and local investors.

For investors, this action signals a commitment to transparency and inclusivity. It reinforces the company's strategy of catering to regional markets, which is a key part of its growth story. This accessibility helps retail investors stay informed without needing to navigate complex financial jargon, ensuring they have a clear view of the company's performance and communication standards.